XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The table below sets forth the share-based awards that have been excluded from the computation of diluted earnings per share because their effect would be anti-dilutive:
 For the Three Months Ended March 31,
 20222021
Anti-Dilutive Options2,347,218 943,838 
Anti-Dilutive Restricted Stock Units2,493,698 66,705 
Anti-Dilutive Performance Share Units2,071,418 — 
6,912,334 1,010,543 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity The table below sets forth the share-based awards that have been exercised or released:
 For the Three Months Ended March 31,
 20222021
Options83,424 656,368 
Restricted Stock Units915,921 701,757 
Performance Share Units72,353 291,653 
1,071,698 1,649,778 
Schedule of Earnings Per Share, Basic and Diluted The computations for basic and diluted loss per share are as follows:
For the Three Months Ended March 31,
 20222021
Net (Loss) Income$(922,941)$98,025 
Weighted-Average Shares of Common Stock Outstanding
199,854,257 219,923,634 
Effect of Diluted Shares*
— 8,746,814 
Weighted-Average Diluted Shares of Common Stock Outstanding
199,854,257 228,670,448 
(Loss) Earnings per Share:
Basic$(4.62)$0.45 
Diluted$(4.62)$0.43 
*During periods in which the Company incurs a net loss, diluted weighted average shares outstanding are equal to basic weighted average shares outstanding because the effect of all equity awards is antidilutive.